Correlation of Visceral Adiposity Index with Visceral Fat in Obese Patients with and without Type 2 Diabetes Mellitus. 2022

Sangameshwara Kalapur, and Charanjit Singh
VMMC and Safdarjung Hospital, New Delhi.

Diabetes and Obesity are major health problems worldwide. Obesity and Diabetes are interrelated. Visceral adiposity is well correlated with insulin resistance, metabolic syndrome and cardiovascular diseases. Visceral Adiposity Index (VAI) is calculated using anthropometric and laboratory data and Visceral Fat is measured radiologically here. Following study evaluated the correlation between them. OBJECTIVE To study correlation of visceral adiposity index with visceral fat in obese patients with and without type 2 Diabetes Mellitus. METHODS Study Design: An observational cross sectional comparative study was conducted which included total 60 obese patients with BMI ≥ 25 kg/m2, of them 30 had type 2 diabetes mellitus (DM) and 30 were non diabetic (NDM). All were aged >40 years with no history of malignancy or any abdominal surgery. METHODS Patients fulfilling inclusion criteria were included in the study after taking informed written consent. Physical examination and anthropometric measurements were done. Blood investigations included Lipid Profile [Total Cholesterol (TC), Serum Triglycerides (TG), High Density Lipoprotein Cholesterol (HDL), Low density Lipoprotein Cholesterol (LDL)], HBA1c, Fasting Blood Glucose (FBS) and Post-Prandial Blood Glucose (PPBS). Liver Kidney Space (LKS) measured by ultrasonography was taken as a parameter for Visceral Fat (VF). VAI was calculated using the necessary formula. RESULTS Mean VAI in DM group was 2.71±1.18 and in NDM group was 2.39±0.58. Mean VF(LKS) in DM group was 4.19±0.27 mm and in NDM group was 4.03±0.29 mm. VAI was significantly higher in females. There was significant correlation (p<0.05) of VAI with VF(LKS) in whole population, in DM group and in NDM group. No significant difference was seen in both DM and NDM in terms of VAI and VF(LKS). LKS was significantly correlated (p<0.05) with Weight, BMI, Waist circumference, FBS, TC, TG, HDL, LDL in whole population, DM and NDM group, with PPBS and HBA1c in whole population and in DM group and with height in NDM group. There was significant correlation (p<0.05) between VAI with PPBS and HBA1c in DM group. CONCLUSIONS VAI and VF(LKS) were well correlated in whole population as well as in both DM and NDM group individually but there was no significant difference between DM and NDM groups. We need large population multicentric study for better assessment and its use in clinical practise.

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006442 Glycated Hemoglobin Products of non-enzymatic reactions between GLUCOSE and HEMOGLOBIN (occurring as a minor fraction of the hemoglobin of ERYTHROCYTES.) It generally refers to glycated HEMOGLOBIN A. Hemoglobin A1c (Hb A1c) is hemoglobin A with GLYCATION on a terminal VALINE of the beta chain. Glycated hemoglobin A is used as an index of the average blood sugar level over a lifetime of erythrocytes. Fructated Hemoglobins,Glycohemoglobin,Glycohemoglobin A,Glycohemoglobins,Glycosylated Hemoglobin A,Hb A1c,HbA1,Hemoglobin A(1),Hemoglobin A, Glycosylated,Glycated Hemoglobin A,Glycated Hemoglobin A1c,Glycated Hemoglobins,Glycosylated Hemoglobin A1c,Hb A1,Hb A1a+b,Hb A1a-1,Hb A1a-2,Hb A1b,Hemoglobin, Glycated A1a-2,Hemoglobin, Glycated A1b,Hemoglobin, Glycosylated,Hemoglobin, Glycosylated A1a-1,Hemoglobin, Glycosylated A1b,A1a-1 Hemoglobin, Glycosylated,A1a-2 Hemoglobin, Glycated,A1b Hemoglobin, Glycated,A1b Hemoglobin, Glycosylated,Glycated A1a-2 Hemoglobin,Glycated A1b Hemoglobin,Glycosylated A1a-1 Hemoglobin,Glycosylated A1b Hemoglobin,Glycosylated Hemoglobin,Hemoglobin A, Glycated,Hemoglobin A1c, Glycated,Hemoglobin A1c, Glycosylated,Hemoglobin, Glycated,Hemoglobin, Glycated A1a 2,Hemoglobin, Glycosylated A1a 1,Hemoglobins, Fructated,Hemoglobins, Glycated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015992 Body Mass Index An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI Quetelet Index,Quetelet's Index,Index, Body Mass,Index, Quetelet,Quetelets Index
D050152 Intra-Abdominal Fat Fatty tissue inside the ABDOMINAL CAVITY, including visceral fat and retroperitoneal fat. It is the most metabolically active fat in the body and easily accessible for LIPOLYSIS. Increased visceral fat is associated with metabolic complications of OBESITY. Abdominal Visceral Fat,Fat, Intra-Abdominal,Intra-Abdominal Adipose Tissue,Retroperitoneal Adipose Tissue,Retroperitoneal Fat,Visceral Adipose Tissue,Visceral Fat,Abdominal Visceral Fats,Adipose Tissue, Intra-Abdominal,Adipose Tissue, Retroperitoneal,Adipose Tissue, Visceral,Fat, Abdominal Visceral,Fat, Intra Abdominal,Fat, Retroperitoneal,Fat, Visceral,Fats, Abdominal Visceral,Fats, Intra-Abdominal,Fats, Retroperitoneal,Fats, Visceral,Intra Abdominal Adipose Tissue,Intra Abdominal Fat,Intra-Abdominal Fats,Retroperitoneal Fats,Visceral Fats
D050154 Adiposity The amount of fat or lipid deposit at a site or an organ in the body, an indicator of body fat status.

Related Publications

Sangameshwara Kalapur, and Charanjit Singh
August 2022, Food science & nutrition,
Sangameshwara Kalapur, and Charanjit Singh
June 2017, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences,
Sangameshwara Kalapur, and Charanjit Singh
May 2021, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Sangameshwara Kalapur, and Charanjit Singh
June 2022, Metabolic syndrome and related disorders,
Sangameshwara Kalapur, and Charanjit Singh
February 2021, Diabetes/metabolism research and reviews,
Sangameshwara Kalapur, and Charanjit Singh
August 2007, Diabetes research and clinical practice,
Sangameshwara Kalapur, and Charanjit Singh
January 2022, Journal of Ayub Medical College, Abbottabad : JAMC,
Sangameshwara Kalapur, and Charanjit Singh
January 2021, Diabetes, metabolic syndrome and obesity : targets and therapy,
Copied contents to your clipboard!